{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:09:15Z","timestamp":1778098155246,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jocn.2018.10.011","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T19:00:46Z","timestamp":1539716446000},"page":"203-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["NMDA receptor antibody in teratoma-related opsoclonus-myoclonus syndrome"],"prefix":"10.1016","volume":"58","author":[{"given":"Nicol\u00e1s X.","family":"Urriola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Helou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Maamary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Pogson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn","family":"Parratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Fulham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Michael","family":"Halm\u00e1gyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.10.011_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-510X(01)00564-0","article-title":"Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates","volume":"189","author":"Wong","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2018.10.011_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","article-title":"Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies","volume":"73","author":"Armangu\u00e9","year":"2016","journal-title":"Jama Neurology"},{"key":"10.1016\/j.jocn.2018.10.011_b0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jamaneurol.2015.4757","article-title":"New findings in adult opsoclonus-myoclonus syndrome","volume":"73","author":"Honnorat","year":"2016","journal-title":"Jama Neurology"},{"key":"10.1016\/j.jocn.2018.10.011_b0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.23917","article-title":"A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2018.10.011_b0025","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archneurol.2011.166","article-title":"N-methyl-d-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis","volume":"68","author":"Smith","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2018.10.011_b0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archneurol.2009.299","article-title":"Opsoclonus-myoclonus syndrome in anti-N-methyl-d-aspartate receptor encephalitis","volume":"67","author":"Kurian","year":"2010","journal-title":"Arch Neurol-Chicago"},{"key":"10.1016\/j.jocn.2018.10.011_b0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.pediatrneurol.2015.07.010","article-title":"Pediatric opsoclonus-myoclonus-ataxia syndrome associated with anti-N-methyl-d-aspartate receptor encephalitis","volume":"53","author":"Player","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jocn.2018.10.011_b0040","article-title":"Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy","volume":"4","author":"Dumitrascu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.10.011_b0045","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-d-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain J Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818307392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818307392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T20:00:26Z","timestamp":1542312026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586818307392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":9,"alternative-id":["S0967586818307392"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.10.011","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMDA receptor antibody in teratoma-related opsoclonus-myoclonus syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}